Molecular Analyzer Binx io® CLIA Waived Sample Dependent

Features

• Binx io is the first ever, FDA-cleared, molecular point-of-care platform that enables clinicians to test and treat women and men for the most common STIs, chlamydia and gonorrhea, in a single office visit
• Binx io is a small, desktop instrument that processes a single-use, assay-specific cartridge with no sample preparation necessary
• The binx io has been cleared by the FDA for use in point-of-care and clinical laboratory settings for the rapid and accurate detection of chlamydia and gonorrhea in vaginal swab and first catch urine samples collected by either a clinician or patient
• 3.30.21 CLIA waived for binx health io Instrument (use with female vaginal swabs and male urine) for both Chlamydia and Neisseria gonorrhoeae